Todd, great post, and timely. Thanks. It is clear that acquisitions can add immediate scale and access to coveted markets. But there is a substantial downside risk that for some reason, becomes a big surprise when that downside presents itself. As of early 2023, less than a handful of Med Device companies had made substantive organizational investments in QA, dedicated to M/A. However, over the last 14 months, we have seen numerous clients identify the need to elevate QA's participation while building the talent needed to make create the QA /RA recipe and then execute in support of the due diligence and integration. Success requires technical savvy, energy, business acumen, and a decisiveness to step up, and deliver pragmatic direction. Need to be tough enough to say 'no', while finding a solution! This is a coveted expertise that companies need; and what a fun opportunity for the right individual.
C-Suite Medical Device Executive / Advisor & Strategic Consultant / Board Member / Executive Coach / Interim Leader / Bellwether League Foundation 2023 Healthcare Hall of Fame Inductee
I had the honor of being invited to be a speaker at last night's OC/Empire ASQ meeting. The group was very welcoming and engaged.... it was a real pleasure to spend some time with them. My topic was "The Role of Quality in the M&A Process". Below is the deck I shared but it was really about the real life stories I shared from experiences on both side of the M&A table and the terrific questions generated by the group.